{"schema":"hottub-news/story/v1","story":"st_mccjn6hphyr5wqyvh5gq","title":"Analyzing Bioventus (NASDAQ:BVS) & Abbott Laboratories (NYSE:ABT)","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/analyzing-bioventus-nasdaq-bvs-abbott-laboratories-nyse-abt-mccjn6hphy","count":1,"items":[{"id":"n_mccjn6hphyr5wqyvh5gq","seq":309755,"kind":"article","title":"Analyzing Bioventus (NASDAQ:BVS) & Abbott Laboratories (NYSE:ABT)","url":"https://www.tickerreport.com/banking-finance/13598668/analyzing-bioventus-nasdaqbvs-abbott-laboratories-nyseabt.html","published":"2026-09-27T22:39:16Z","seen":"2026-09-27T22:39:16Z","lang":"en","source":{"id":"tickerreport.com","name":"tickerreport.com","domain":"tickerreport.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Ethan Ryder"],"entities":[{"id":"Q306764","name":"Abbott Laboratories","type":"org"}],"mentions":2,"story":"st_mccjn6hphyr5wqyvh5gq","category":"economy-business","category_p":0.5,"category2":"science-technology","sentiment":"neutral","tone":-0.019999999552965164,"political":0.019999999552965164}]}